Health And Wellness
You can buy or sell PolarityTE and other stocks, options, ETFs, and crypto commission-free!
PolarityTE, Inc. Common Stock, also called PolarityTE, is a commercial-stage biotechnology and regenerative biomaterials company, which focuses on discovering, designing and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Read More Its products include SkinTE, OsteoTE and Real Time Assistant. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.
Salt Lake City, Utah
52 Week High
52 Week Low
Health And Wellness
Simply Wall StMar 21
PolarityTE, Inc. (NASDAQ:PTE): Will The Growth Last?
PolarityTE, Inc.’s (NASDAQ:PTE) most recent earnings update in December 2018 indicated that losses became smaller relative to the prior year’s level as a result of recent tailwinds Today I want to provide a brief commentary on how market analysts predict PolarityTE’s earnings growth trajectory over the next couple of years and whether the future looks brighter. I will be using net income excluding extraordinary items in order to exclude one-off volatility which I am not interested in. View our latest analy...
PR NewswireMar 21
PolarityTE Hosts Symposium Featuring SkinTE-Treated Burn Survivor, New Clinical Data at American Burn Association Annual Meeting
SALT LAKE CITY, March 21, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today it will host a symposium at the American Burn Association (ABA) 51st Annual Meeting featuring a burn survivor who will share her story after being treated with the Company's SkinTE™ product. Additionally, two abstracts on the clinical use of SkinTE will be presented during the conference. The ABA Annual Meeting w...
Seeking AlphaMar 21
Evercore likes PolarityTE in premarket analyst action
Aerie Pharmaceuticals (NASDAQ:AERI) initiated with Overweight rating and $80 (74% upside) price target at Piper Jaffray. PolarityTE (NASDAQ:PTE) initiated with Outperform rating and $26 (117% upside) price target at Evercore ISI. Shares up 9% premarket. Diplomat Pharmacy (NYSE:DPLO) upgraded to Outperform with an $8 (37% upside) price target at Raymond James....
-$1.04 per share
-$1.47 per share